PL402549A1 - Dopochwowa kompozycja farmaceutyczna i zastosowanie - Google Patents

Dopochwowa kompozycja farmaceutyczna i zastosowanie

Info

Publication number
PL402549A1
PL402549A1 PL402549A PL40254902A PL402549A1 PL 402549 A1 PL402549 A1 PL 402549A1 PL 402549 A PL402549 A PL 402549A PL 40254902 A PL40254902 A PL 40254902A PL 402549 A1 PL402549 A1 PL 402549A1
Authority
PL
Poland
Prior art keywords
bioadhesive
pharmaceutical composition
dysrhythmic
therapeutic agent
treatment
Prior art date
Application number
PL402549A
Other languages
English (en)
Inventor
Howard L. Levine
William J. Bologna
Ziegler Dominique De
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of PL402549A1 publication Critical patent/PL402549A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Wynalazek dotyczy kompozycji farmaceutycznej do leczenia lub zapobiegania bólowi w obrebie miednicy, leczenia dysrytmii macicy, albo nieplodnosci lub poprawy zaburzonej plodnosci zwiazanych dysrytmia macicy. Kompozycja obejmuje srodek leczniczy przeciwko dysrytmii do podawania miejscowego i bioadhezyjny nosnik do przedluzonego uwalniania. Kompozycja moze byc dostarczana w postaci preparatu o przedluzonym uwalnianiu, który obejmuje bioadhezyjny, zdolny do pecznienia, nierozpuszczalny w wodzie usieciowany polimer polikarboksylowy, taki jak polikarbofii. Srodek leczniczy moze byc miejscowo znieczulajacy, taki jak lidokaina. Wynalazek dotyczy równiez zastosowania leczniczego srodka przeciwko dysrytmii i farmaceutycznie dopuszczalnego bioadhezyjnego nosnika do wytwarzania leku.
PL402549A 2001-10-29 2002-10-28 Dopochwowa kompozycja farmaceutyczna i zastosowanie PL402549A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33068401P 2001-10-29 2001-10-29
US10/278,912 US20030114394A1 (en) 2001-10-29 2002-10-24 Vaginally administered anti-dysrhythmic agents for treating pelvic pain

Publications (1)

Publication Number Publication Date
PL402549A1 true PL402549A1 (pl) 2013-08-05

Family

ID=26959337

Family Applications (2)

Application Number Title Priority Date Filing Date
PL02369790A PL369790A1 (pl) 2001-10-29 2002-10-28 Podawane dopochwowo środki przeciwko dysrytmii macicy do leczenia bólu w obrębie miednicy
PL402549A PL402549A1 (pl) 2001-10-29 2002-10-28 Dopochwowa kompozycja farmaceutyczna i zastosowanie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL02369790A PL369790A1 (pl) 2001-10-29 2002-10-28 Podawane dopochwowo środki przeciwko dysrytmii macicy do leczenia bólu w obrębie miednicy

Country Status (33)

Country Link
US (1) US20030114394A1 (pl)
EP (2) EP1441770B1 (pl)
JP (2) JP2005511564A (pl)
KR (2) KR20050040820A (pl)
CN (1) CN100404072C (pl)
AR (1) AR037048A1 (pl)
AT (2) ATE346614T1 (pl)
AU (1) AU2002350644B2 (pl)
BR (1) BR0213585A (pl)
CA (1) CA2465132C (pl)
CY (2) CY1106000T1 (pl)
DE (2) DE60234725D1 (pl)
DK (2) DK1441770T3 (pl)
ES (2) ES2336238T3 (pl)
GE (1) GEP20094614B (pl)
HR (1) HRP20040479B1 (pl)
HU (1) HUP0402389A3 (pl)
IL (3) IL161513A0 (pl)
MA (1) MA26230A1 (pl)
ME (1) ME00255B (pl)
MX (1) MXPA04003976A (pl)
MY (2) MY149482A (pl)
NO (1) NO333544B1 (pl)
NZ (1) NZ532295A (pl)
PE (1) PE20030692A1 (pl)
PL (2) PL369790A1 (pl)
PT (2) PT1764111E (pl)
RS (1) RS51414B (pl)
RU (2) RU2345758C2 (pl)
SI (2) SI1441770T1 (pl)
UA (1) UA90077C2 (pl)
WO (1) WO2003037381A1 (pl)
ZA (1) ZA200402944B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341737B2 (en) * 1997-06-11 2008-03-11 Kimberly-Clark Worldwide, Inc. Medicated tampon
US7344732B2 (en) * 2002-01-10 2008-03-18 Kimberly-Clark Worldwide, Inc. Medicated tampon
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7527614B2 (en) 2005-03-25 2009-05-05 Kimberly-Clark Worldwide, Inc. Protective tube for a medicated tampon
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
US20080108824A1 (en) * 2006-09-28 2008-05-08 Med Institute, Inc Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices
WO2008039995A2 (en) * 2006-09-28 2008-04-03 Vance Products Incorporated, D/Ba Cook Urological Incorporated Medical device including a bioactive in a non-ionic and an ionic form and methods of preparation thereof
US20080081829A1 (en) * 2006-09-28 2008-04-03 Med Institute, Inc Medical Device Including an Anesthetic and Method of Preparation Thereof
ES2696999T3 (es) * 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Dispositivos de administración intravaginal de medicamentos para la administración de macromoléculas y medicamentos solubles en agua
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8475823B2 (en) * 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
MX2010011880A (es) * 2008-04-29 2011-05-25 Pharnext Nuevos enfoques terapeuticos para tratar la enfermedad del alzheimer y trastornos relacionados mediante una modulacion de la respuesta de estres celular.
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
RU2538674C2 (ru) * 2012-09-10 2015-01-10 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Фармацевтическая композиция, обладающая пролонгированной противоаритмической активностью
WO2015051336A1 (en) 2013-10-03 2015-04-09 David Wise Compositions and methods for treating pelvic pain and other conditions
JP6654057B2 (ja) * 2016-02-10 2020-02-26 国立大学法人 筑波大学 局所麻酔薬を含有するポリイオンコンプレックスを有効成分とする局所疼痛制御用組成物
WO2017165707A1 (en) * 2016-03-24 2017-09-28 Juniper Pharmaceuticals, Inc. Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures
BR102018008324A2 (pt) * 2018-04-25 2019-11-05 Laboratórios Ferring Ltda. composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3387419A (en) * 1965-10-22 1968-06-11 Kamberg Henry Decking with trim strip
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
CA2072623C (en) * 1989-11-03 2001-03-27 Matthew T. Scholz Bioadhesive composition and patch
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US5663492A (en) * 1996-06-05 1997-09-02 Alapati; Rama Rao System for continuous analysis and modification of characteristics of a liquid hydrocarbon stream
US5985861A (en) * 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US5977143A (en) * 1997-02-15 1999-11-02 Edelstam; Greta Medicament against infertility which reduces phagocytosis of spermatozoa in women
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
CA2207227A1 (en) * 1997-06-09 1998-12-09 Johnson & Johnson Inc. Plant seed germination mat
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6248358B1 (en) * 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
DE69833000T2 (de) * 1997-09-26 2006-09-07 Noven Pharmaceuticals, Inc., Miami Bio-klebemittelzusammensetzungen
US6135153A (en) * 1998-01-02 2000-10-24 Cleland, Sr. John Anesthesia delivery systems and methods
US6180355B1 (en) * 1998-05-07 2001-01-30 University Of Maryland, Baltimore Method for diagnosing and treating chronic pelvic pain syndrome
US6207696B1 (en) * 1998-09-15 2001-03-27 Cytos Pharamaceuticals, Llc Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6486207B2 (en) * 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
AU7331300A (en) * 1999-08-27 2001-03-26 Merck & Co., Inc. Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Also Published As

Publication number Publication date
UA90077C2 (uk) 2010-04-12
DE60216495T2 (de) 2007-07-26
ZA200402944B (en) 2005-03-30
HUP0402389A3 (en) 2012-09-28
SI1764111T1 (sl) 2010-04-30
RU2004116346A (ru) 2005-03-10
HRP20040479B1 (hr) 2009-02-28
MXPA04003976A (es) 2004-07-08
SI1441770T1 (sl) 2007-02-28
EP1764111B1 (en) 2009-12-09
MA26230A1 (fr) 2004-07-01
CY1106000T1 (el) 2011-04-06
HK1102221A1 (en) 2007-11-09
EP1764111A1 (en) 2007-03-21
DE60216495D1 (de) 2007-01-11
BR0213585A (pt) 2004-08-24
PT1764111E (pt) 2010-01-29
RS36704A (sr) 2006-10-27
CN100404072C (zh) 2008-07-23
AU2002350644B2 (en) 2008-05-08
HRP20040479A2 (en) 2004-10-31
HUP0402389A2 (hu) 2005-03-29
NO333544B1 (no) 2013-07-08
US20030114394A1 (en) 2003-06-19
GEP20094614B (en) 2009-02-25
MEP34908A (bs) 2011-02-10
EP1441770B1 (en) 2006-11-29
NZ532295A (en) 2006-12-22
PE20030692A1 (es) 2003-08-28
IL211288A (en) 2014-02-27
CA2465132A1 (en) 2003-05-08
EP1441770A1 (en) 2004-08-04
IL161513A0 (en) 2004-09-27
ES2275928T3 (es) 2007-06-16
ATE346614T1 (de) 2006-12-15
AR037048A1 (es) 2004-10-20
RS51414B (sr) 2011-02-28
HK1063293A1 (en) 2004-12-24
CN1578675A (zh) 2005-02-09
RU2008133235A (ru) 2010-02-20
KR20100088718A (ko) 2010-08-10
NO20042208L (no) 2004-07-29
RU2476212C2 (ru) 2013-02-27
JP2005511564A (ja) 2005-04-28
JP2011201909A (ja) 2011-10-13
PL369790A1 (pl) 2005-05-02
IL211288A0 (en) 2011-04-28
MY145215A (en) 2012-01-13
DK1764111T3 (da) 2010-04-06
CA2465132C (en) 2012-04-24
DK1441770T3 (da) 2007-03-19
PT1441770E (pt) 2007-01-31
WO2003037381A1 (en) 2003-05-08
ATE451123T1 (de) 2009-12-15
ME00255B (me) 2011-05-10
RU2345758C2 (ru) 2009-02-10
KR20050040820A (ko) 2005-05-03
IL161513A (en) 2011-12-29
DE60234725D1 (de) 2010-01-21
CY1110288T1 (el) 2015-01-14
ES2336238T3 (es) 2010-04-09
MY149482A (en) 2013-08-30

Similar Documents

Publication Publication Date Title
BR0213585A (pt) Composição vaginal farmacêutica, e, usos de um agente de tratamento antidisrìtmico e de um carreador bioadesivo de liberação prolongada farmaceuticamente aceitável, e de um agente de tratamento anestésico local e de um carregador bioadesivo de liberação prolongada farmaceuticamente aceitável
IL135258A0 (en) Bioadhesive compositions and methods for topical administration of active agents
PT969813E (pt) Composicao farmaceutica topica compreendendo um agente colinergico ou um bloqueador de canal de calcio
BR0112571A (pt) Método para o tratamento de fêmeas humanas, composição farmaceuticamente aceitável e dispositivo para aplicação intravaginal ou transvaginal de um agente farmacêutico antifúngico, antiviral, antibacteriano ou parasiticida
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
UA81638C2 (ru) Композиция метронидазола для местного применения для лечения заболеваний аноректального и перианального участков
BR0007360A (pt) Composição de liberação controlada
DE60141145D1 (pl)
NZ602538A (en) Thermogelling anaesthetic compositions
EP0966966A3 (en) Nefazodone dosage form
MXPA03000548A (es) Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
PT1608349E (pt) Sistema de administração oral que compreende um agente antibacteriano e um agente anti-inflamatório
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
IL132853A (en) Composition for modulating the human sexual response
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
WO2001021194A3 (en) Method for the therapeutic management of endometriosis and fallopian tube obstruction
HRP20020258B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
CR6627A (es) Nuevo medicamento contraceptivo y su modo de preparacion
JP2003516957A5 (pl)
TW200600089A (en) Vaginally administered anti-dysrhythmic agents for treating pelvic pain
UA95691C2 (ru) Фармацевтическая вагинальная композиция и ее применение
BR0314959A (pt) Emplastro transdérmico de 17beta-estradiol/levonorgestrel para terapia de reposição hormonal
CA2431519A1 (en) Topical composition and method for treating urinary stress incontinence
CO5580799A2 (es) Agentes anti-disritmicos administrados vaginalmente para tratar el dolor pelvico e infertilidad
UA33773A (uk) Засіб для лікування патології нервово-м'язової системи та опірно-рухового апарату "ревмокаїн"

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)